Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, and the inventory tumbles
Novo Nordisk’s stock tumbles after its oral GLP-1 drug failed to show much benefit over a placebo against Alzheimer’s.
Trending
- Brian Cole: The DC Pipe Bomber
- Physician Who Compelled His Girlfriend to Take Abortion Drugs Indicted on Six Felony Prices
- NEW: Supreme Courtroom Approves Pink State Congressional Map That May Determine Midterm Elections
- SCOTUS Greenlights Texas’ New Congressional Map (For Now)
- NHL futures: Risers, fallers and why playoff odds have not caught as much as the Sharks
- Will Derek Chauvin Be Freed? There’s Now a Critical Problem to the Ex-cop’s Conviction
- ICE seeks removing of unlawful immigrant felony suspect in hit-and-run that killed 11-year-old woman
- Western coalition supplying tech to Ukraine ready for lengthy conflict | JP
- JUST IN: Pentagon Pronounces twenty second Strike On Drug-Trafficking Vessels
- Even the Washington Publish Is aware of Congress Can Defund Deliberate Parenthood